cheetah
popul
namibia
largest
freerang
popul
world
key
popul
research
regard
health
statu
speci
use
serolog
method
quantit
realtim
pcr
test
freerang
captiv
namibian
cheetah
presenc
felin
leukemia
viru
felv
gammaretroviru
highli
aggress
popul
low
genet
divers
cheetah
also
assess
presenc
antibodi
gammaretrovirus
respons
felv
vaccin
develop
domest
cat
freerang
cheetah
captiv
nonvaccin
cheetah
captiv
vaccin
cheetah
test
posit
felv
antibodi
felvantibodyposit
freerang
cheetah
also
test
posit
rauscher
murin
leukemia
viru
antibodi
nevertheless
felv
detect
quantit
realtim
pcr
revers
transcriptas
activ
detect
productenhanc
revers
transcriptas
assay
plasma
cheetah
supernat
cultur
peripher
blood
mononuclear
cell
presenc
antibodi
gammaretrovirus
clinic
healthi
specimen
may
caus
either
infect
lowpathogen
retroviru
express
endogen
retrovir
sequenc
strong
humor
immun
respons
felv
vaccin
demonstr
cheetah
respond
vaccin
vaccin
felv
infect
may
benefici
felv
infect
ever
becom
threat
seen
iberian
lynx
florida
panther
cheetah
popul
namibia
largest
freerang
popul
vulner
speci
decad
cheetah
consid
highli
suscept
infecti
diseas
low
genet
variabl
assum
impair
immun
respons
viral
challeng
evid
fatal
viral
infect
cheetah
come
outbreak
felin
infecti
periton
fip
consequ
felin
coronaviru
fcov
infect
captiv
popul
unit
state
kept
nonetholog
high
densiti
singl
case
rapid
felin
leukemia
viru
felv
diseas
progress
captiv
namibian
cheetah
diseas
outbreak
report
freerang
cheetah
popul
sever
studi
identifi
antibodi
virus
felin
herpesviru
fhv
felin
caliciviru
fcv
felin
parvoviru
fpv
fcov
canin
distemp
viru
cdv
felin
immunodefici
viru
fiv
rabi
viru
namibia
freerang
cheetah
gener
good
health
clinic
sign
viral
infect
detect
sampl
none
histopatholog
examin
conduct
necropsi
show
lesion
relat
viral
infect
recent
studi
major
histocompat
complex
mhc
class
class
ii
confirm
rel
low
genet
variabl
cheetah
despit
small
number
mhc
class
allel
allel
namibian
cheetah
still
mount
effect
immun
respons
viral
challeng
although
immunocompet
might
limit
confront
new
pathogen
thu
import
continu
monitor
freerang
cheetah
popul
namibia
particularli
virus
antibodi
report
far
felv
oncogen
gammaretroviru
felv
particular
interest
case
cheetah
experienc
rapid
deterior
die
infect
transmit
captiv
cheetah
test
posit
felv
antigen
circumstanti
evid
indic
origin
infect
nonvaccin
feral
domest
cat
virem
felv
method
transmiss
cours
diseas
also
observ
florida
panther
puma
concolor
coryi
iberian
lynx
lynx
pardinu
endang
freerang
felid
speci
namibia
cheetah
roam
mainli
commerci
use
farmland
might
come
contact
nonvaccin
feral
domest
cat
dog
well
freerang
leopard
panthera
pardu
smaller
carnivor
previou
studi
document
cheetah
northcentr
namibia
higher
seropreval
fhv
fcv
fcov
cdv
cheetah
eastcentr
namibia
probabl
consequ
greater
contact
frequenc
due
like
higher
densiti
mostli
nonvaccin
feral
domest
cat
dog
region
greater
human
popul
goal
present
report
studi
discuss
natur
antibodi
felv
close
relat
retroviru
present
portion
serum
sampl
freerang
captiv
namibian
cheetah
also
examin
efficaci
vaccin
felv
induc
antibodi
felv
captiv
cheetah
studi
anim
sampl
retrospect
studi
blood
sampl
collect
june
juli
freerang
cheetah
male
femal
commerci
farmland
eastcentr
namibia
analyz
studi
sampl
anim
live
close
human
settlement
potenti
contact
domest
cat
also
sampl
cheetah
male
femal
held
enclosur
within
natur
habitat
thirti
captiv
cheetah
hous
africat
foundat
nonprofit
conserv
facil
carnivor
central
namibia
privat
own
farm
collect
heparin
plasma
sampl
freerang
cheetah
collect
heparin
plasma
andor
serum
sampl
edtatr
wholeblood
sampl
cheetah
hous
africat
captiv
cheetah
hous
privat
farm
sampl
collect
time
may
provid
evid
seroconvers
anim
repeatedli
use
sampl
collect
freerang
cheetah
five
sampl
twice
one
sampl
three
time
one
sampl
four
time
among
captiv
cheetah
seven
sampl
twice
two
sampl
three
time
one
sampl
four
time
one
anim
sampl
freerang
cheetah
later
captiv
cheetah
count
categori
interv
repeat
sampl
time
rang
month
month
studi
use
serum
heparin
plasma
sampl
freerang
cheetah
serum
heparin
plasma
sampl
captiv
cheetah
addit
use
edtatr
wholeblood
sampl
freerang
cheetah
captiv
cheetah
depend
question
examin
differ
sampl
set
use
see
statist
analysi
freerang
captiv
anim
captur
anesthet
sampl
clinic
examin
bodi
size
determin
weight
temperatur
measur
bodi
palpat
visual
check
sign
infect
releas
describ
previous
captiv
anim
examin
part
annual
health
checkup
includ
vaccin
develop
domest
cat
fhv
fcv
fpv
felv
tricat
nobivac
contain
attenu
fhv
fcv
fpv
nonglycosyl
envelop
gene
product
express
escherichia
coli
felovax
lvk
contain
kill
felv
rabi
rabisin
merial
midrand
south
africa
contain
inactiv
rabi
viru
thirti
plasma
sampl
origin
cheetah
vaccin
sever
year
five
plasma
sampl
origin
nonvaccin
cheetah
vaccin
first
time
day
examin
test
month
month
later
sampl
collect
vena
saphena
vena
cephalica
heparin
serum
edta
blood
collect
tube
bd
vacutain
system
plymouth
unit
kingdom
sampl
kept
transport
field
station
central
veterinari
laboratori
windhoek
namibia
plasma
serum
wholeblood
sampl
store
liquid
nitrogen
peripher
blood
mononuclear
cell
pbmc
isol
heparin
blood
sampl
captiv
freerang
cheetah
ficol
gradient
use
histopaqu
sigmaaldrich
buch
switzerland
hank
balanc
salt
solut
hbss
invitrogen
basel
switzerland
describ
previous
store
liquid
nitrogen
plasma
serum
wholeblood
sampl
pbmc
transport
switzerland
dri
ice
dri
shipper
voyageur
air
liquid
pari
franc
full
complianc
convent
intern
trade
endang
speci
cite
enzymelink
immunoabsorb
assay
serum
plasma
sampl
test
felv
antigen
use
sandwich
enzymelink
immunoabsorb
assay
elisa
describ
previous
sampl
reach
optic
densiti
od
positivecontrol
valu
consid
trueposit
sampl
sampl
reach
positivecontrol
valu
consid
question
sampl
valu
consid
trueneg
sampl
also
determin
presenc
antibodi
felv
nonglycosyl
form
surfac
unit
envelop
glycoprotein
whole
felv
purifi
ultracentrifug
elisa
describ
dilut
antibodi
level
assess
comparison
predefin
positivecontrol
sera
consist
pool
sera
collect
felv
regressor
cat
determin
elisa
cutoff
valu
measur
mean
plasma
od
valu
specificpathogenfre
spf
cat
n
assay
duplic
percentag
positivecontrol
valu
assign
cutoff
valu
set
mean
valu
plu
time
standard
deviat
confid
interv
neg
result
determin
cutoff
valu
elisa
perform
way
spf
cat
compil
number
anim
sampl
freerang
captiv
nonvaccin
captiv
vaccin
cheetah
use
test
present
tabl
western
blot
analysi
western
blot
wb
use
determin
presenc
antibodi
felv
two
fragment
e
use
dilut
sampl
use
serum
plasma
sampl
freerang
cheetah
serum
plasma
sampl
captiv
cheetah
depend
question
examin
differ
sampl
set
use
see
statist
analysi
sampl
show
antibodi
felv
plu
one
two
e
fragment
e
fragment
consid
posit
antibodi
reactiv
retrovirus
test
serum
sampl
six
randomli
chosen
felvwbposit
six
felvwbneg
freerang
cheetah
sampl
test
reactiv
follow
retrovirus
gener
gift
hl
us
nation
cancer
institut
baboon
endogen
retroviru
felin
endogen
retroviru
rauscher
murin
leukemia
viru
rmulv
akr
murin
leukemia
viru
akrmulv
antibodi
visual
assess
wb
use
g
antigen
per
strip
viru
prepar
dilut
sampl
total
nucleic
acid
extract
total
nucleic
acid
tna
extract
l
edtatr
blood
n
l
heparin
plasma
n
addit
l
mgcl
cacl
free
phosphatebuff
salin
pb
invitrogen
volum
magna
pure
lc
tna
isol
kit
roch
diagnost
rotkreuz
switzerland
use
follow
manufactur
instruct
tna
elut
l
buffer
roch
store
analysi
realtim
pcr
presenc
amplifi
dna
wholeblood
tna
sampl
extract
control
test
quantit
realtim
pcr
assay
felin
dehydrogenas
fgapdh
describ
previous
presenc
amplifi
exogen
felv
viral
rna
dna
determin
realtim
revers
transcriptas
rt
pcr
realtim
pcr
respect
wholeblood
plasma
tna
wholeblood
tna
test
amplifi
endogen
felv
sequenc
describ
previous
productenhanc
revers
transcriptas
assay
pbmc
cultur
ml
medium
consist
rpmi
medium
sigma
inactiv
fetal
calf
serum
invitrogen
lglutamin
invitrogen
antibioticantimycot
invitrogen
cell
cultur
flask
tpp
trasadingen
switzerland
l
concanavalin
mgml
sigma
ad
day
uml
interleukin
sandoz
pharmaceut
ag
cham
switzerland
ad
cultur
five
millilit
medium
uml
ad
cultur
day
ml
medium
replac
uml
ad
cultur
everi
day
week
ml
supernat
collect
centrifug
min
g
store
aliquot
week
cell
frozen
store
liquid
nitrogen
rt
activ
assess
supernat
collect
fourth
week
pbmc
cultur
swiss
nation
center
retrovirus
univers
zurich
zurich
switzerland
use
productenhanc
revers
transcriptas
pert
assay
rt
activ
also
assess
heparin
plasma
sampl
wband
elisaneg
anim
potenti
inhibit
heparin
exclud
test
posit
rt
sampl
togeth
aliquot
without
heparin
inhibit
observ
correct
measur
rt
valu
necessari
statist
analysi
test
perform
use
systat
systat
softwar
inc
richmond
va
assess
whether
vaccin
anim
differ
nonvaccin
anim
serolog
assay
use
three
categori
freerang
captiv
nonvaccin
captiv
vaccin
cheetah
nonvaccin
anim
sampl
repeatedli
randomli
select
one
test
result
analys
anim
repres
analys
five
captiv
anim
test
nonvaccin
vaccin
use
nonvaccin
result
vaccin
anim
vaccin
sever
year
see
result
serolog
data
normal
distribut
lilliefor
test
p
comparison
perform
use
nonparametr
kruskalw
test
wb
result
assess
use
chisquar
test
result
male
femal
anim
group
test
compar
fisher
exact
test
none
studi
anim
show
clinic
sign
infecti
diseas
fever
enlarg
lymph
node
pale
mucu
membran
anemia
prolong
capillari
refil
time
letharg
dehydr
serolog
assay
elisa
none
freerang
captiv
nonvaccin
captiv
vaccin
cheetah
test
posit
tabl
seven
repeatedli
test
freerang
cheetah
five
seven
repeatedli
test
captiv
nonvaccin
cheetah
neg
test
none
five
captiv
cheetah
sampl
nonvaccin
anim
year
later
vaccin
felv
turn
posit
three
africat
cheetah
kept
facil
africat
foundat
vaccin
sever
year
test
question
other
test
neg
ii
elisa
one
freerang
three
captiv
nonvaccin
captiv
vaccin
cheetah
test
posit
tabl
three
repeatedli
test
freerang
cheetah
two
three
repeatedli
test
captiv
nonvaccin
cheetah
reveal
result
repeat
test
two
five
captiv
cheetah
sampl
nonvaccin
anim
year
later
vaccin
anim
test
posit
sampl
two
test
neg
sampl
one
anim
turn
neg
posit
twentytwo
africat
cheetah
test
posit
od
valu
differ
three
categori
kruskalw
test
statist
p
freerang
n
nonvaccin
n
vaccin
n
captiv
vaccin
cheetah
higher
valu
freerang
cheetah
conoverinman
test
pairwis
comparison
p
captiv
nonvaccin
cheetah
p
freerang
cheetah
od
valu
similar
captiv
nonvaccin
cheetah
p
fig
iii
wholeviru
elisa
seventeen
freerang
seven
captiv
nonvaccin
captiv
vaccin
cheetah
test
posit
tabl
six
seven
repeat
sum
anim
greater
total
number
anim
anim
captur
test
repeatedli
classifi
differ
od
level
see
text
c
sum
anim
greater
total
number
anim
anim
test
plasma
serum
classifi
differ
od
level
see
text
edli
test
freerang
cheetah
five
seven
repeatedli
test
captiv
nonvaccin
cheetah
reveal
result
repeat
test
two
five
captiv
cheetah
sampl
nonvaccin
anim
year
later
vaccin
anim
test
posit
sampl
two
test
neg
sampl
one
anim
turn
neg
posit
twentyseven
africat
cheetah
test
posit
od
valu
differ
three
categori
kruskalw
test
statist
p
freerang
n
nonvaccin
n
vaccin
n
captiv
vaccin
cheetah
higher
valu
freerang
cheetah
conoverinman
test
pairwis
comparison
p
captiv
nonvaccin
cheetah
p
antibodi
viru
increas
time
presenc
africat
facil
r
p
freerang
cheetah
od
valu
similar
captiv
nonvaccin
cheetah
p
fig
western
blot
twentyseven
freerang
captiv
nonvaccin
captiv
vaccin
cheetah
posit
tabl
three
repeatedli
test
freerang
cheetah
reveal
result
repeat
test
two
five
captiv
cheetah
sampl
nonvaccin
anim
year
later
vaccin
anim
test
posit
sampl
two
test
neg
sampl
one
anim
turn
contrari
expect
posit
neg
vaccin
africat
cheetah
differ
captiv
nonvaccin
freerang
cheetah
proport
posit
neg
sampl
freerang
posit
n
freerang
neg
n
nonvaccin
posit
n
nonvaccin
neg
n
vaccin
posit
n
vaccin
neg
n
p
none
cheetah
test
posit
four
test
perform
freerang
captiv
nonvaccin
captiv
vaccin
cheetah
test
posit
least
one
test
nine
five
nine
respect
posit
second
test
four
one
respect
posit
three
test
signific
differ
proport
seroposit
seroneg
male
femal
elisa
elisa
wb
six
felvwbposit
six
felvwbneg
freerang
anim
select
wb
evalu
four
retrovirus
six
wbposit
anim
also
demonstr
antibodi
two
e
fragment
rmulv
six
wbneg
anim
test
neg
four
retrovirus
realtim
pcr
forti
wholeblood
tna
sampl
show
accept
amount
genom
dna
copiesreact
select
analysi
pcr
assay
endogen
exogen
felv
neg
anim
pert
assay
test
pbmc
cultur
seven
wbposit
sampl
one
wbneg
sampl
freerang
anim
pert
assay
neg
rt
activ
cell
cultur
supernat
numl
plasma
wband
elisaneg
anim
numl
positivecontrol
sampl
activ
rang
numl
felv
infect
freerang
felid
threaten
entir
popul
date
freerang
namibian
felid
popul
spare
retrovir
infect
kalahari
desert
may
act
natur
barrier
keep
namibian
popul
naiv
pathogen
present
adjac
countri
captiv
vaccin
cheetah
higher
od
level
freerang
p
captiv
nonvaccin
p
cheetah
wherea
latter
two
similar
od
level
p
box
whisker
plot
lower
line
percentil
middl
line
percentil
upper
line
percentil
whisker
percentil
respect
outlier
captiv
vaccin
cheetah
higher
od
level
freerang
p
captiv
nonvaccin
p
cheetah
wherea
latter
two
similar
od
level
p
box
whisker
plot
lower
line
percentil
middl
line
percentil
upper
line
percentil
whisker
percentil
respect
outlier
studi
detect
antibodi
felv
rmulv
felv
viral
dna
revers
transcriptas
activ
pbmc
plasma
sampl
kalahari
desert
natur
barrier
pathogen
undetect
retroviru
trigger
measur
antibodi
felv
rmulv
namibian
cheetah
might
endem
one
previou
studi
test
carnivor
felv
use
antigen
test
wherea
also
use
antibodi
test
studi
use
antibodi
test
also
countri
across
kalahari
desert
might
provid
new
insight
distribut
retrovirus
southern
africa
antibodi
abl
recogn
felv
crossreact
rmulv
distantli
relat
baboon
felin
endogen
retroviru
specul
namibian
cheetah
either
infect
retroviru
harbor
differenti
express
endogen
retroviru
belong
gammaretroviru
mammalian
group
subfamili
antibodi
reactiv
e
akrmulv
detect
although
akrmulv
e
differ
felv
rmulv
e
one
amino
acid
posit
thu
observ
cheetah
antibodi
recogn
akrmulv
e
could
explain
fact
akrmulv
e
differ
conform
epitop
present
felv
rmulv
e
altern
presenc
reactiv
antibodi
rmulv
six
felvwbposit
sampl
might
due
activ
endogen
gammaretrovirus
directli
relat
infecti
diseas
similar
observ
report
recent
human
diagnos
recentonset
psychosi
subject
develop
antibodi
crossreact
mulv
masonpf
monkey
viru
simian
dtype
betaretroviru
wherea
patient
longterm
schizophrenia
control
subject
exhibit
crossreact
antibodi
although
underli
caus
unlik
import
cheetah
aberr
endogen
retroviru
express
might
also
trigger
factor
report
involv
defect
mice
spermatogenesi
defect
spermatogenesi
result
teratospermia
ie
product
morpholog
abnorm
sperm
per
ejacul
wellknown
phenomenon
felid
particularli
cheetah
howev
capac
ejacul
proven
unproven
cheetah
male
breeder
insemin
oozyt
vitro
differ
suggest
teratospermia
cheetah
major
concern
captiv
freerang
popul
particularli
world
largest
popul
namibia
still
aberr
endogen
retroviru
express
might
involv
product
teratosperm
ejacul
cheetah
eventu
becom
problemat
particular
individu
teratospermia
reach
level
lead
infertil
domest
cat
virem
felv
antibodyposit
sampl
may
show
low
level
replic
viru
wherea
virem
cat
sampl
low
undetect
antibodi
level
may
product
infect
high
level
replic
viru
therefor
sampl
felvwbposit
wbneg
anim
use
pert
assay
neg
pert
result
may
due
complet
repress
viru
antibodyposit
anim
absenc
infect
antibodyneg
anim
anim
product
infect
might
exist
wild
rare
infect
might
short
phase
viremia
anim
rather
low
probabl
captur
sampl
addit
analys
use
exampl
target
highthroughput
sequenc
genom
dna
would
requir
identifi
unknown
retrovir
strain
fact
anim
healthi
also
suggest
viru
may
pathogen
andor
short
cours
infect
hypothesi
support
recent
demonstr
nearli
asymptomat
experiment
infect
mu
pahari
mice
strain
lack
endogen
murin
leukemia
virus
gammaretroviru
restrict
factor
seen
transspeci
total
test
sampl
consid
posit
antibodi
detect
felv
plu
one
two
e
fragment
e
fragment
b
sum
anim
greater
total
number
anim
anim
captur
test
repeatedli
posit
differ
fragment
see
text
c
six
e
posit
six
e
neg
sampl
freerang
cheetah
use
test
antibodi
reactiv
four
addit
retrovirus
berv
baboon
endogen
retroviru
felin
endogen
retroviru
rmulv
rauscher
murin
leukemia
viru
akrmlv
akr
murin
leukemia
viru
nd
done
six
e
posit
sampl
also
e
posit
sampl
transmiss
model
gammaretrovirus
xenotrop
murin
leukemia
virusrel
gammaretroviru
xmrv
viral
rna
detect
plasma
infect
mice
infect
mice
develop
persist
neutral
antibodi
direct
gag
env
protein
therefor
analog
situat
mu
pahari
specul
cheetah
context
hunt
becom
expos
gammaretroviru
present
wild
mice
viru
might
abl
transient
infect
cheetah
develop
effect
immun
respons
seroconvert
abl
overcom
retrovir
infect
altern
cheetah
may
react
lowlevel
exposur
felv
like
domest
cat
domest
cat
expos
experiment
low
level
felv
seroconvers
felv
observ
felv
provir
dna
found
present
small
amount
intern
organ
good
health
statu
seroposit
cheetah
suggest
despit
rel
low
mhc
class
variabl
cheetah
popul
mount
effect
immun
respons
gammaretroviru
investig
studi
low
mhc
variabl
howev
might
limit
immunocompet
individu
confront
new
pathogen
namibian
cheetah
potenti
suscept
felv
captiv
anim
prevent
vaccin
vaccin
wide
use
domest
cat
attempt
assess
magnitud
immun
respons
cheetah
vaccin
accord
protocol
use
domest
cat
cheetah
hous
africat
vaccin
sever
year
higher
od
valu
freerang
captiv
nonvaccin
cheetah
similar
od
valu
similar
pattern
antigen
recognit
wb
increas
level
antibodi
viru
cheetah
long
resid
africat
explain
repeat
felv
vaccin
thu
test
antibodi
viru
seem
use
assess
effect
felv
vaccin
antibodi
induct
also
cheetah
posit
respons
antigen
respect
vaccin
cheetah
africat
conclud
cheetah
readili
respond
felv
vaccin
howev
five
captiv
anim
vaccin
retest
year
later
one
anim
demonstr
higher
od
valu
second
test
support
concept
boost
may
induc
increas
level
antibodi
howev
increas
level
antibodi
necessarili
ident
protect
view
presenc
domest
cat
infect
felv
might
use
continu
vaccin
program
captiv
anim
conclus
detect
presenc
antibodi
react
felvrel
gammaretroviru
namibian
cheetah
anim
good
health
conclud
infect
unknown
origin
may
endem
namibian
cheetah
affect
anim
mount
effici
immun
respons
cope
viru
despit
low
mhc
variabl
replic
viru
detect
studi
requir
identifi
origin
felvvaccin
cheetah
could
mount
immun
respons
vaccin
appear
meaning
continu
vaccin
program
felv
prevent
measur
captiv
anim
